Current Value of Holding

$13.8 Million

Shares

708 Thousand

% of Portfolio

0.01%

Average Buy Price

$34.5

Avg closing price
Price range

20 Ken Griffin Celldex Therapeutics Trades

Ken Griffin acquired 708 Thousand Celldex Therapeutics shares worth $13.8 Million. That's 0.01% of their equity portfolio (1004th largest holding). The investor owns 1.01% of the outstanding Celldex Therapeutics stock. The first Celldex Therapeutics trade was made in Q4 2019. Since then Ken Griffin bought shares eleven more times and sold shares on eight occasions. The investor's estimated purchase price is $24.4 Million, resulting in a loss of 43%.

Avg closing price
Price range
Sold 16.4% shares (-139 Thousand shares) Q4 2024
Avg closing price $27.13
Price range $23.31 - $32.40
Increased shares by 163.8% (+526 Thousand shares) Q3 2024
Avg closing price $38.12
Price range $32.06 - $44.56
Increased shares by 275.9% (+236 Thousand shares) Q2 2024
Avg closing price $37.73
Price range $32.76 - $42.56
Sold 32.4% shares (-40.9 Thousand shares) Q1 2024
Avg closing price $41.06
Price range $35.22 - $51.88
Increased shares by 2032.1% (+120 Thousand shares) Q4 2023
Avg closing price $29.41
Price range $22.61 - $40.65
Sold 93.5% shares (-84.8 Thousand shares) Q3 2023
Avg closing price $31.35
Price range $25.45 - $37.46
Sold 93.2% shares (-1.24 Million shares) Q2 2023
Avg closing price $33.70
Price range $30.29 - $38.28
Increased shares by 75.7% (+575 Thousand shares) Q1 2023
Avg closing price $43.15
Price range $34.78 - $47.43
Sold 49.4% shares (-741 Thousand shares) Q4 2022
Avg closing price $35.70
Price range $27.78 - $45.38
Increased shares by 43.8% (+457 Thousand shares) Q3 2022
Avg closing price $30.66
Price range $22.70 - $37.57
Sold 8.0% shares (-91.1 Thousand shares) Q2 2022
Avg closing price $29.04
Price range $20.50 - $37.33
Increased shares by 6.1% (+65.8 Thousand shares) Q1 2022
Avg closing price $31.97
Price range $27.64 - $39.32
Increased shares by 36.6% (+286 Thousand shares) Q4 2021
Avg closing price $43.58
Price range $35.68 - $56.27
Increased shares by 111.0% (+412 Thousand shares) Q3 2021
Avg closing price $46.92
Price range $28.95 - $55.99
Sold 62.0% shares (-605 Thousand shares) Q2 2021
Avg closing price $27.45
Price range $20.71 - $35.37
Increased shares by 3780.9% (+951 Thousand shares) Q1 2021
Avg closing price $22.96
Price range $16.19 - $29.91
Sold 57.7% shares (-34.4 Thousand shares) Q3 2020
Avg closing price $11.71
Price range $9.65 - $15.19
Increased shares by 142.8% (+35 Thousand shares) Q2 2020
Avg closing price $4.43
Price range $1.61 - $13.41
Increased shares by 55.7% (+8.77 Thousand shares) Q1 2020
Avg closing price $2.26
Price range $1.55 - $3.07
New holding (+15.7 Thousand shares) Q4 2019
Avg closing price $2.32
Price range $2.11 - $2.80

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!